Pain Relief

Product NDC
21130-323
11-digit product format
211300323
Labeler code
21130
Product ID
21130-323_b0ea17bd-6a2b-4df7-8c86-cf597873176e
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen
Dosage form
SUSPENSION
Route
ORAL
Labeler
Safeway, Inc.
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2015-06-30
Marketing end
2021-12-30
Substance
ACETAMINOPHEN
Active strength
160 mg/5mL
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct21130-323DDiscontinued by firm2026-10-12
excluded packagepackage21130-32321130-323-02DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage21130-323-02d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage21130-323-02f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage21130-323-022ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage21130-323-02a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage21130-323-02cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage21130-323-02cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage21130-323-02302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage21130-323-02ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage21130-323-020efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage21130-323-02ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage21130-323-02367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage21130-323-02557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
ACETAMINOPHENACTIVE MOIETY362O9ITL9DPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSLPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV8PAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORMINACTIVE INGREDIENTK679OBS311PAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
HIGH FRUCTOSE CORN SYRUPINACTIVE INGREDIENTXY6UN3QB6SPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3PAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
SORBITOLINACTIVE INGREDIENT506T60A25RPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
SUCRALOSEINACTIVE INGREDIENT96K6UQ3ZD4PAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEEPAIN RELIEF DYE FREE INFANTS (ACETAMINOPHEN) SUSPENSION [SAFEWAY, INC.]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
21130-323-02211300323021 BOTTLE in 1 BOX (21130-323-02) > 59 mL in 1 BOTTLE1 bottle2015-06-302021-12-30NoNoCurrent